Naltrexone vs "Lotrexone": They Are The Same Medication
"Lotrexone" is not a distinct medication—it appears to be a misspelling or misunderstanding of naltrexone itself. There is no FDA-approved drug called "lotrexone" or any generic variant by that name. The confusion may stem from "low-dose naltrexone" (LDN), which refers to naltrexone prescribed at doses of 1-5 mg rather than the standard 50 mg dose 1.
Understanding Naltrexone Formulations
Naltrexone is available in several legitimate forms:
Standard Oral Naltrexone
- Dose: 50 mg daily 1
- FDA-approved indications: Opioid use disorder and alcohol use disorder 2, 1
- Pharmacokinetics: 4-hour half-life for parent drug, 13-hour half-life for active metabolite (6-β-naltrexol), with antagonist effects persisting 2-3 days after discontinuation 3, 1
- Mechanism: Competitive μ-opioid receptor antagonist that blocks euphoric effects of opioids and reduces alcohol consumption 1
Extended-Release Injectable Naltrexone (Vivitrol®)
- Dose: Once-monthly injection 4, 5
- Advantage: Eliminates daily adherence issues that limit oral naltrexone effectiveness 4, 5
- Evidence: Potentially more effective than oral naltrexone for alcohol dependence in primary care settings 5
Low-Dose Naltrexone (LDN)
- Dose: 1-5 mg daily (typically 4.5 mg) 6, 7
- Use: Off-label for chronic pain conditions (fibromyalgia, neuropathy, complex regional pain syndrome) and inflammatory dermatologic conditions 6, 7
- Mechanism: Transiently blocks opioid receptors, paradoxically increasing endogenous opioid production and reducing inflammatory mediators through toll-like receptor 4 antagonism 6
- Important: Must be compounded by pharmacy—not commercially available 6
- Effectiveness: Modest pain reduction (average -0.83 on pain scale), generally well-tolerated but with limited robust evidence 7
Critical Clinical Distinctions
Perioperative Management
Hold oral naltrexone 2-3 days before elective surgery if opioids will be used perioperatively 3. The active metabolite persists and will block postoperative opioid analgesia, potentially leading to inadequate pain control or dangerous opioid dose escalation attempting to overcome the blockade 3, 1.
Opioid Use Disorder Treatment
For patients with opioid use disorder, medication-assisted treatment with buprenorphine or methadone is preferred over naltrexone 2. Naltrexone can be used in non-pregnant adults but requires complete opioid detoxification first (7-10 days opioid-free) to avoid precipitating severe withdrawal 2, 1. No waiver is needed to prescribe naltrexone, unlike buprenorphine 2.
Alcohol Use Disorder
Standard 50 mg daily naltrexone reduces relapse rates (31% vs 60% placebo), drinking days, and alcohol craving when combined with psychosocial support 1. Recent evidence supports its safety even in severe alcohol-associated cirrhosis 8.
Common Pitfalls
- Precipitated withdrawal: Never give naltrexone to opioid-dependent patients without adequate detoxification period 1
- Overcoming blockade: Attempting to override naltrexone blockade with high-dose opioids can cause excessive histamine release and toxicity 1
- Hepatotoxicity concerns: While naltrexone has been associated with hepatotoxicity at high doses, current evidence shows it is safe in cirrhosis; avoid only in acute hepatitis or acute-on-chronic liver failure 8
- Compounding access: LDN requires pharmacy compounding, creating potential access barriers 6